Sideris Pharmaceuticals
Latest round
- Series A
Last raised
- Oct 2013
Total raised
- $32M
Investors
- 3
About Sideris Pharmaceuticals
Sideris Pharmaceuticals is based in the United States and operates as an independent biopharmaceutical company focused on the development of treatments for diseases of iron overload, including conditions involving maintenance transfusion therapy.
Who invested in Sideris Pharmaceuticals
3 investors across 1 round
See all investors in Sideris Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Oct 22, 2013
Amount
$32M
Investors
Questions about Sideris Pharmaceuticals
Who invested in Sideris Pharmaceuticals?
Sideris Pharmaceuticals has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Sideris Pharmaceuticals raised?
Sideris Pharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Sideris Pharmaceuticals last raise money?
Sideris Pharmaceuticals's most recent round on record is a Series A, in Oct 2013.
What does Sideris Pharmaceuticals do?
Sideris Pharmaceuticals is based in the United States and operates as an independent biopharmaceutical company focused on the development of treatments for diseases of iron overload, including conditions involving maintenance transfusion therapy.
Where is Sideris Pharmaceuticals headquartered?
Sideris Pharmaceuticals is headquartered in Boston, US.
Which VCs invest in companies like Sideris Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Sideris Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Sideris Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.